Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

[edit this page]

Thollon, C. et al.

Thollon, Bedut, Villeneuve, Cog??, Piffard, Guillaumin, Brunel-Jacquemin, Chomarat, Boutin, Peglion, Vilaine,

Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity.

Background and purpose:Ivabradine, a specific and use-dependent I (f) inhibitor, exerts anti-ischaemic activity purely by reducing heart rate. The aim of this work was to characterize its effect on the predominant HCN channel isoform expressed in human sino-atrial nodes (hSAN), to determine its kinetics in HCN channels from multicellular preparations and rate-dependency of its action.Experimental approach:RT-PCR analysis of the four HCN channel isoforms was carried out on RNAs from hSAN. Patch-clamp and intracellular recordings were obtained from CHO cells stably expressing hHCN4 and isolated SAN, respectively. Beating rate of rat isolated atria was followed using a transducer.Key results:hHCN4 mRNAs were predominant in hSAN. Ivabradine induced a time-dependent inhibition of hHCN4 with an IC(50) of 0.5 muM. In rabbit SAN, ivabradine progressively reduced the frequency of action potentials: by 10% after 3 h at 0.1 muM, by 14% after 2 h at 0.3 muM and by 17% after 1.5 h at 1 muM. After 3h, ivabradine reduced the beating rate of rat right atria with an IC(30) of 0.2 muM. The onset of action of ivabradine was use-dependent rather than time-dependent with slower effects than caesium, an extracellular I (f) blocker. Ivabradine 3 muM decreased the frequency of action potentials in SAN from guinea-pig, rabbit and pig by 33%, 21% and 15% at 40 min, respectively.Conclusions and implications:The use-dependent inhibition of hHCN4 current by ivabradine probably contributes to its slow developing effect in isolated SAN and right atria and to its increased effectiveness in species with rapid SAN activity.British Journal of Pharmacology (2007) 150, 37-46. doi:10.1038/sj.bjp.0706940; published online 27 November 2006.[1]

References

Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity. Thollon, C., Bedut, S., Villeneuve, N., Cog??, F., Piffard, L., Guillaumin, J.P., Brunel-Jacquemin, C., Chomarat, P., Boutin, J.A., Peglion, J.L., Vilaine, J.P. Br. J. Pharmacol. (2007) [Pubmed]

Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenes Open Access Licence Privacy Policy Terms of Use apsburg

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.